| Validity and reliability of the Alzheimer's disease cooperative study-clinical global impression of change LS Schneider, JT Olin, RS Doody, CM Clark, JC Morris, B Reisberg, ... Alzheimer Disease & Associated Disorders 11, 22-32, 1997 | 708 | 1997 |
| Cancer linked to Alzheimer disease but not vascular dementia CM Roe, AL Fitzpatrick, C Xiong, W Sieh, L Kuller, JP Miller, MM Williams, ... Neurology 74 (2), 106-112, 2010 | 339 | 2010 |
| Variolins and related alkaloids SR Walker, EJ Carter, BC Huff, JC Morris Chemical reviews 109 (7), 3080-3098, 2009 | 292 | 2009 |
| Meriolins (3-(pyrimidin-4-yl)-7-azaindoles): synthesis, kinase inhibitory activity, cellular effects, and structure of a CDK2/cyclin A/meriolin complex A Echalier, K Bettayeb, Y Ferandin, O Lozach, M Clément, A Valette, ... Journal of medicinal chemistry 51 (4), 737-751, 2008 | 182 | 2008 |
| Meriolins, a new class of cell death–inducing kinase inhibitors with enhanced selectivity for cyclin-dependent kinases K Bettayeb, OM Tirado, S Marionneau-Lambot, Y Ferandin, O Lozach, ... Cancer Research 67 (17), 8325-8334, 2007 | 176 | 2007 |
| Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury. L Mucke, MB Oldstone, JC Morris, MI Nerenberg The New biologist 3 (5), 465-474, 1991 | 168 | 1991 |
| The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity A Collison, L Hatchwell, N Verrills, PAB Wark, AP De Siqueira, M Tooze, ... Nature medicine 19 (2), 232-237, 2013 | 163 | 2013 |
| Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial SM Mills, J Mallmann, AM Santacruz, A Fuqua, M Carril, PS Aisen, ... Revue neurologique 169 (10), 737-743, 2013 | 157 | 2013 |
| Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia X Han, AM Fagan, H Cheng, JC Morris, C Xiong, DM Holtzman Annals of neurology 54 (1), 115-119, 2003 | 135 | 2003 |
| A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism N Turner, XY Lim, HD Toop, B Osborne, AE Brandon, EN Taylor, ... Nature communications 9 (1), 3165, 2018 | 134 | 2018 |
| Brief screening tests versus clinical staging in senile dementia of the Alzheimer type PB Davis, JC Morris, E Grant Journal of the American Geriatrics Society 38 (2), 129-135, 1990 | 134 | 1990 |
| Dibenzotetraphenylperiflanthene: synthesis, photophysical properties, and electrogenerated chemiluminescence JD Debad, JC Morris, V Lynch, P Magnus, AJ Bard Journal of the American Chemical Society 118 (10), 2374-2379, 1996 | 129 | 1996 |
| MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity JJ Li, HL Tay, S Maltby, Y Xiang, F Eyers, L Hatchwell, H Zhou, HD Toop, ... Journal of allergy and clinical immunology 136 (2), 462-473, 2015 | 111 | 2015 |
| Pharmacology of modulators of alternative splicing DO Bates, JC Morris, S Oltean, LF Donaldson Pharmacological reviews 69 (1), 63-79, 2017 | 105 | 2017 |
| Development of potent, selective SRPK1 inhibitors as potential topical therapeutics for neovascular eye disease J Batson, HD Toop, C Redondo, R Babaei-Jadidi, A Chaikuad, ... ACS chemical biology 12 (3), 825-832, 2017 | 104 | 2017 |
| The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease A Gerrish, G Russo, A Richards, V Moskvina, D Ivanov, D Harold, R Sims, ... Journal of Alzheimer's Disease 28 (2), 377-387, 2012 | 92 | 2012 |
| Recordings from the stomatogastric nervous system in intact lobsters J Morris, DM Maynard Elsevier, 1970 | 82 | 1970 |
| Sustained attention in young people at high risk for schizophrenia R Cosway, M Byrne, R Clafferty, A Hodges, E Grant, J Morris, ... Psychological Medicine 32 (2), 277-286, 2002 | 78 | 2002 |
| Anodic Coupling of Diphenylbenzo[k]fluoranthene: Mechanistic and Kinetic Studies Utilizing Cyclic Voltammetry and Electrogenerated Chemiluminescence JD Debad, JC Morris, P Magnus, AJ Bard The Journal of Organic Chemistry 62 (3), 530-537, 1997 | 77 | 1997 |
| SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4 K Tzelepis, E De Braekeleer, D Aspris, I Barbieri, MS Vijayabaskar, ... Nature communications 9 (1), 5378, 2018 | 74 | 2018 |
David BatesUniversity of NottinghamCorreu electrònic verificat a nottingham.ac.uk